Drugs / DHA-O
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03691519 | Apr 2018 → Mar 2020 | Alzheimer disease | University Hospital, Toulouse | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DHA-O | “Patient in the "treatment comparative arm will consume 3- 1g softgel vegetarian capsules of DHA-O per day as a single dose for 36 months; each 1g capsule of DHA-0 providing 324...” NCT03691519 ↗ |
| Route | Oral | “will consume 3- 1g softgel vegetarian capsules of DHA-O per day as a single dose for 36 months” NCT03691519 ↗ |